Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07807644
PHASE2

A Clinical Trial of GRT7040 in Adults With Acute Pain Following Bunionectomy

Sponsor: Grünenthal GmbH

View on ClinicalTrials.gov

Summary

This is a Phase 2 clinical trial of GRT7040, currently being developed for the treatment of moderate-to-severe acute pain. The primary purpose of this trial is to assess efficacy and safety of GRT7040 compared with placebo in adult participants with acute pain following bunionectomy. The trial will compare three different doses of GRT7040 given from Day 1 until Day 3 (eg, 48 h after the first investigational medicinal product \[IMP\] administration) of GRT7040 or placebo.

Official title: A Randomized, Double-Blind, Double-Dummy, Placebo- and Active-Controlled, 2-Part Phase 2 Trial to Investigate the Efficacy and Safety of GRT7040 in Adult Participants With Acute Pain Following Bunionectomy

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

400

Start Date

2026-09

Completion Date

2027-09

Last Updated

2026-09-08

Healthy Volunteers

No

Interventions

DRUG

GRT7040

The trial will compare three different doses of GRT7040 (Low, Medium \[Mid\] and High doses)

DRUG

Hydrocodone bitartrate/ acetaminophen (HB/APAP)

Reference drug

DRUG

Placebo (matched to HB/APAP)

Dummy treatment

DRUG

Placebo (matched to GRT7040)

Dummy treatment